Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.270NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.270NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.270NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.227NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.227NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.227NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
U.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
U.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
U.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.28NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.28NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.15NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.15NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.24NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.24NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.236NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.236NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.236NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.153NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.153NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.153NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.302NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.302NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.302NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.194NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.194NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.194NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.55NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.55NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.55NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.308NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.308NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.308NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.138NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.138NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.138NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.379NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.379NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.379NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.240NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.240NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.240NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.240.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.240.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used